Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 916-603-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study performed according to OECD guideline 408 in compliance to GLP.
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
- Reference Type:
- other: Published secondary source
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- Multi constituent substance
- EC Number:
- 916-603-5
- IUPAC Name:
- Multi constituent substance
- Details on test material:
- Test substance : Basic Red 76 (COLIPA number C008)
Batch number : 0057891101
Methylsulphate anion : 15.9%
Chloride ion : 2.7%
Water : 4.1%
o-Anisidine : 19ppm
Purity : 98.6% (HPLC)
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: distilled water
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- The test substance and vehicle control were administered once daily by oral gavage for 91 consecutive days.
- Frequency of treatment:
- Once daily
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
60 mg/kg bw
Basis:
actual ingested
- Remarks:
- Doses / Concentrations:
250 mg/kg bw
Basis:
actual ingested
- Remarks:
- Doses / Concentrations:
1000 mg/kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- Twelve/sex/dose group. Five/sex/dose group for recovery (4 weeks)
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- The test substance was administered as an aqueous solution in a single dose by gavage for 91 consecutive days in daily doses of 60, 250 and 1000 mg/kg bw/day based on the results of the dose range finding study of the prenatal developmental toxicity study (0, 200, 600, 1000 mg/kg bw/day). The control animals received the vehicle alone. During the study mortality, signs of toxicity, body weight and food consumption were recorded. Functional observation tests were performed in week 12. Ophthalmoscopy was performed before the start of treatment and in week 13. The animals of the recovery groups were additionally examined during the 4 week treatment free period. At the end of the study the animals were sacrificed and subjected to pathological investigations.
Results and discussion
Results of examinations
- Details on results:
- No mortality occurred that was considered to be due to the toxicity of the test item. One female of the 60 mg/kg bw/day dose group was found dead on day 60. Based on microscopic and macroscopic findings the cause of death was considered to be related to the dosing procedure. All other animals survived the duration of the study.
Red staining of various body parts and red discolouration of faeces and urine observed among the dose groups were considered to be related to the staining properties of the test item and/or a metabolite and is considered to be of no toxicological significance.
Clonic spasms observed in some animals of all dose groups after treatment including the control group in the last few weeks of treatment were considered not to be significant in toxicological terms. This observation was of an intermittent and infrequent nature and was not supported by abnormalities during functional observation testing.
No toxicologically relevant changes in body weight and food intake quantities were observed and no abnormalities were seen during ophthalmoscopic examination.
At 250 and 1000 mg/kg bw/day effects on haematology parameters were indicative of destruction of red blood cells and included increased tissue iron storage in the spleen and liver and increased serum bilirubin levels. Elevated numbers of reticulocytes, increased severity of extramedullary haemopoiesis in the spleen and erythropoiesis in the sternal bone marrow indicate a regenerative response to the lower red blood cell counts. Congestion of the spleen and increased spleen weights (with enlargement) were related to these processes. Increased methaemoglobin formation at 250 and 1000 mg/kg bw/day indicates that the test item may convert haem to the ferric state. The increased incidence/severity of hemosiderin pigment in the spleen at 1000 mg/kg bw/day at the end of the recovery period may indicate a residual presence of tissue iron storage. Based on normal red blood cell counts and the absence of extramedullary haematopoiesis it was considered that haematological effects had widely resolved during the 4 week recovery period.
Thyroid follicular hypertrophy in combination with hypertrophy of the adenohypophyseal cells of the pituitary as observed at the 1000 mg/kg bw/day dose level probably reflect a perturbation of thyroid-pituitary hormone homeostasis.
At 250 and 1000 mg/kg bw/day there was clear evidence of an adverse effect of the test item on red blood cell life span as indicated by evidence for haemolysis and increased methaemoglobin levels at these dose levels. At 60 mg/kg bw/day evidence for an effect on red blood cell turn over was marginal in nature and occurred in the absence of any evidence of red blood cell destruction or increased extramedullary haematopoiesis and was considered not to reflect an adverse effect on red blood cell turn over.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 60 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- haematology
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- In a subchronic toxicity study a NOAEL of 60 mg/kg bw/day was determined following treatment by oral gavage in rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.